AANA Publishes Considerations for Anesthesia Care of the Patient on a GLP-1 Receptor Agonist
March 12, 2024
March 12, 2024
ROSEMONT, Illinois, March 12 -- The American Association of Nurse Anesthesiology issued the following news release:
Glucagon-like peptide-1 (GLP-1) agonists such as Ozempic(R) or Wegovy(R) (semaglutide), Saxenda(R) (liraglutide), or Zepbound(TM) (tirzepatide), have become increasingly popular in promoting weight loss. To support the safety of patients and the knowledge of anesthesia professionals, such as Certified Registered Nurse Anesthetists (CRNAs), also known as nurse anesthesi . . .
Glucagon-like peptide-1 (GLP-1) agonists such as Ozempic(R) or Wegovy(R) (semaglutide), Saxenda(R) (liraglutide), or Zepbound(TM) (tirzepatide), have become increasingly popular in promoting weight loss. To support the safety of patients and the knowledge of anesthesia professionals, such as Certified Registered Nurse Anesthetists (CRNAs), also known as nurse anesthesi . . .